LISA HARRIS: Open Payments
NPI 1609395110 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,688 in 101 payments from 18 companies in 2025. Trend: 2023 $1,551 · 2024 $3,147 · 2025 $2,688
Food & beverage: $2,688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $470 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $413 |
| Vanda Pharmaceuticals Inc. | 21 | $389 |
| Otsuka America Pharmaceutical, Inc. | 10 | $253 |
| Janssen Pharmaceuticals, Inc | 9 | $164 |
| Lundbeck LLC | 7 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $137 |
| Lilly USA, LLC | 1 | $125 |
| Alkermes, Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
Products named: VRAYLAR, CAPLYTA, REXULTI, FANAPT, SPRAVATO, TRINTELLIX, ZEPBOUND, LYBALVI.
Industry payments across FL — which companies pay providers there.
